Kuchay, Mohammad ShafiMartinez-Montoro, Jose IgnacioLlamoza-Torres, Camilo JulioFernandez-Garcia, Jose CarlosRamos-Molina, Bruno2023-05-032023-05-032022-09-05Kuchay MS, Martínez-Montoro JI, Llamoza-Torres CJ, Fernández-García JC, Ramos-Molina B. Liver cirrhosis and sarcopenia: a dreadful combination. Hepatobiliary Surg Nutr. 2022 Oct;11(5):729-7312304-3881http://hdl.handle.net/10668/21770Patients with liver cirrhosis, irrespective of etiology, have increased risk of liver-related and all-cause mortality (1). Also, the severity of cirrhosis determines health outcomes. For instance, patients with compensated cirrhosis have a nearly five-fold increased risk of death, while those with decompensated cirrhosis have approximately a 10-fold increased risk compared with the general population (1). Furthermore, the median survival time of patients with compensated cirrhosis is 12 years, while it is only 1.8 years in those with decompensated cirrhosis (2). Moreover, the presence of intercurrent conditions, such as sarcopenia (loss of skeletal muscle mass and function) may also compromise the prognosis of patients with cirrhosis (3).enAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/FibrosisSarcopeniaDeathLiver CirrhosisMortalityHumansPrognosisMuscle, SkeletalOutcome Assessment, Health Careresearch article36268240open accessFibrosisMúsculo esqueléticoHígadoPronósticoCirrosis hepática10.21037/hbsn-22-355PMC9577976https://hbsn.amegroups.com/article/viewFile/101565/pdfhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577976/pdf